BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8611517)

  • 21. Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.
    Baum EZ; Siegel MM; Bebernitz GA; Hulmes JD; Sridharan L; Sun L; Tabei K; Johnston SH; Wildey MJ; Nygaard J; Jones TR; Gluzman Y
    Biochemistry; 1996 May; 35(18):5838-46. PubMed ID: 8639545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
    Salhany JM; Sloan RL; Cordes KS
    Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rationally designed monomeric variant of anthranilate phosphoribosyltransferase from Sulfolobus solfataricus is as active as the dimeric wild-type enzyme but less thermostable.
    Schwab T; Skegro D; Mayans O; Sterner R
    J Mol Biol; 2008 Feb; 376(2):506-16. PubMed ID: 18164726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
    Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
    Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.
    Bonneau PR; Grand-Maître C; Greenwood DJ; Lagacé L; LaPlante SR; Massariol MJ; Ogilvie WW; O'Meara JA; Kawai SH
    Biochemistry; 1997 Oct; 36(41):12644-52. PubMed ID: 9376371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folding and self-assembly of herpes simplex virus type 1 thymidine kinase.
    Wurth C; Thomas RM; Folkers G; Scapozza L
    J Mol Biol; 2001 Oct; 313(3):657-70. PubMed ID: 11676546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
    Towler EM; Gulnik SV; Bhat TN; Xie D; Gustschina E; Sumpter TR; Robertson N; Jones C; Sauter M; Mueller-Lantzsch N; Debouck C; Erickson JW
    Biochemistry; 1998 Dec; 37(49):17137-44. PubMed ID: 9860826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A helical coat protein recognition domain of the bacteriophage P22 scaffolding protein.
    Tuma R; Parker MH; Weigele P; Sampson L; Sun Y; Krishna NR; Casjens S; Thomas GJ; Prevelige PE
    J Mol Biol; 1998 Aug; 281(1):81-94. PubMed ID: 9680477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease.
    Pray TR; Nomura AM; Pennington MW; Craik CS
    J Mol Biol; 1999 Jun; 289(2):197-203. PubMed ID: 10366498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
    Tomasselli AG; Paddock DJ; Curry KA; Garlick RL; Leone JW; Lull JM; Mutchler VT; Baker CA; Cavey GS; Mathews WR; Shelly JA; Finzel BC; Baldwin ET; Wells PA; Tomich CS
    Protein Expr Purif; 1998 Dec; 14(3):343-52. PubMed ID: 9882568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of proteolysis in caspase-8 activation and stabilization.
    Pop C; Fitzgerald P; Green DR; Salvesen GS
    Biochemistry; 2007 Apr; 46(14):4398-407. PubMed ID: 17371051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
    Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
    Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of internal autocleavage on kinetic properties of the human cytomegalovirus protease catalytic domain.
    O'Boyle DR; Wager-Smith K; Stevens JT; Weinheimer SP
    J Biol Chem; 1995 Mar; 270(9):4753-8. PubMed ID: 7876248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced structure of a helical switch as a mechanism to regulate enzymatic activity.
    Nomura AM; Marnett AB; Shimba N; Dötsch V; Craik CS
    Nat Struct Mol Biol; 2005 Nov; 12(11):1019-20. PubMed ID: 16244665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.
    Wondrak EM; Louis JM
    Biochemistry; 1996 Oct; 35(39):12957-62. PubMed ID: 8841142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of tobacco etch virus protease shows the protein C terminus bound within the active site.
    Nunn CM; Jeeves M; Cliff MJ; Urquhart GT; George RR; Chao LH; Tscuchia Y; Djordjevic S
    J Mol Biol; 2005 Jul; 350(1):145-55. PubMed ID: 15919091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional role of the N-terminal region of the Lon protease from Mycobacterium smegmatis.
    Roudiak SG; Shrader TE
    Biochemistry; 1998 Aug; 37(32):11255-63. PubMed ID: 9698372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation.
    Baum EZ; Ding WD; Siegel MM; Hulmes J; Bebernitz GA; Sridharan L; Tabei K; Krishnamurthy G; Carofiglio T; Groves JT; Bloom JD; DiGrandi M; Bradley M; Ellestad G; Seddon AP; Gluzman Y
    Biochemistry; 1996 May; 35(18):5847-55. PubMed ID: 8639546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
    Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
    J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.